Myocardial Akt activation and gender: Increased nuclear activity in females versus males

Circulation Research

Volumn 88, Issue 10, 2001, Pages 1020-1027

  Camper Kirby, Dreama ^a   Welch, Sara ^a   Walker, Angela ^a   Shiraishi, Isao ^a   Setchell, Kenneth D R ^a   Schaefer, Erik ^b   Kajstura, Jan ^c   Anversa, Piero ^c   Sussman, Mark A ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b Biosource International   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Akt; Gender; Insulin like growth factor 1; Phytoestrogen; Survival

Indexed keywords

ESTRADIOL; ESTROGEN; GENISTEIN; PROTEIN KINASE B; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL SURVIVAL; ENZYME ACTIVATION; FEMALE; GENETIC TRANSCRIPTION; HEART PROTECTION; HUMAN; HUMAN TISSUE; MALE; METABOLISM; MOUSE; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

EID: 0035947744     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh1001.090858     Document Type: Article

References (55)

1. Cardiovascular pharmacology of hormone replacement therapy
2. Gender differences in molecular remodeling in pressure overload hypertrophy
3. The roles of gender, the menopause and hormone replacement on cardiovascular function
4. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
5. Beyond the null hypothesis: Do the HERS results disprove the estrogen/coronary heart disease hypothesis?
6. Predictors of congestive heart failure in the elderly: The cardiovascular health study
7. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB
8. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
9. PI3K: Downstream AKTion blocks apoptosis
10. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
11. PKB/Akt: Connecting phosphoinositide 3-kinase to cell survival and beyond
12. The PI3K-PDK1 connection: More than just a road to PKB
13. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy
14. Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy
15. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I
16. Insulin-like growth factor-I improves recovery of cardiac performance during repurfusion in isolated rat heart by a wortmannin-sensitive mechanism
17. Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro
18. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart
19. Interaction of the oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
20. Membrane receptor estrogen engagement activates endothelial nitric oxide synthase via the PI3-K-Akt pathway in human endothelial cells
21. Role of translocation in the activation and function of protein kinase B
22. Regulated nuclear localization of stress-responsive factors: How the nuclear trafficking of protein kinases and transcription factors contributes to cell survival
23. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1
24. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor
25. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway
26. Altered expression of tropomodulin in cardiomyocytes disrupts the sarcomeric structure of myofibrils
27. Pathogenesis of dilated cardiomyopathy: Molecular, structural, and population analyses in tropomodulin-overexpressing transgenics
28. Nonenzymatic separation of myocardial cell nuclei from whole heart tissue
29. The phytoestrogens genistein and daidzein and 17 β-estradiol inhibit development of neointima in aortas from male and female rabbits in vitro after injury
30. Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring
31. Genistein exerts estrogen-like effects in male mouse reproductive tract
32. Estrogen receptor α rapidly activates the IGF-1 receptor pathway
33. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus: Altered signaling response to estradiol in the IGF-1 (m/m) mouse
34. Role of AKT1 in 17β-estradiol- and insulin-like growth factor 1 (IGF-1)-dependent proliferation and prevention of apoptosis in Mcf-7 breast carcinoma cells
35. 17β-estradiol prevents programmed cell death in cardiac myocytes
36. Cardiac myocytes contain functional estrogen receptors
37. Differential effects of 17 β-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes
38. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats
39. Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities
40. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice
41. CREB is a regulatory target for the protein kinase Akt/PKB
42. Induction of NF-κB by the Akt/PKB kinase
43. Akt suppresses apoptosis by stimulating the transactivation potential of the Re1A/p65 subunit of NF-κB
44. Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK): A novel nuclear target of Akt
45. Dilated cardiomyopathy in transgenic mice expressing a dominant negative CREB transcription factor in the heart
46. Myocyte death in the failing human heart is gender dependent
47. Cardiovascular and renal benefits of dry bean and soybean intake
48. Phyto-oestrogens. A potential role in the prevention of CHD?
49. Phytoestrogens and cardiovascular health
50. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
51. Mechanism of action for the soy isoflavone genistein: Emerging role for its effects via transforming growth factor β signaling pathways
52. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones
53. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists
54. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
55. Phytoestrogen content of purified, open- and closed-formula laboratory animal diets